FULC vs MCK · $427.0M cap vs P/E 20, rev $403.43B
Fulcrum Therapeutics Inc (FULC) versus McKesson Corporation (MCK) — a side-by-side from cached financials, not a winner call.
Fulcrum Therapeutics Inc (FULC) is a biotechnology company listed on US.
McKesson Corporation (MCK) is a medical distribution company listed on NYSE.
Latest reported FULC revenue for 2025-09-30 was $0. Net income was -$54.5M. FULC currently screens at market cap $427.0M.
Latest reported MCK revenue for 2026-03-31 was $403.43B. Net income was $4.76B. Revenue was up 12.4% from 2025-03-31 to 2026-03-31. MCK currently screens at market cap $91.30B and trailing P/E 20.3.
FULC currently screens at market cap $427.0M. MCK currently screens at market cap $91.30B and trailing P/E 20.3.
Not investment advice. Open the FULC and MCK stock pages for the full models.
Not investment advice.